Objective: To determine insulin sensitivity and skeletal muscle fatty acid (FA) handling at baseline and after a high-fat mixed meal in impaired fasting glucose (IFG), impaired glucose tolerance (IGT), IFG/IGT and normal glucose tolerance (NGT) subjects. Design: In this multi-center study, insulin sensitivity and b-cell function were assessed (n ¼ 102), using a euglycemichyperinsulinemic and hyperglycemic clamp with additional arginine stimulation and a 75 g oral glucose tolerance test. Fasting and postprandial skeletal muscle FA handling was examined in a substudy using the forearm balance technique (n ¼ 35). Subjects: A total of 102 subjects with IFG (n ¼ 48), IGT (n ¼ 12), IFG/IGT (n ¼ 26) and NGT (n ¼ 16). Results: IFG, IGT and IFG/IGT subjects had lower insulin sensitivity with no differences between groups, and lower impaired b-cell function compared with NGT controls. The early postprandial increase in triacylglycerol (TAG) concentration was higher (iAUC 0À2 h IFG: 238.4 ± 26.5, IGT: 234.0 ± 41.0 and NGT: 82.6 ± 13.8 mmol l À1 min À1 , both Po0.05) and early TAG extraction was increased (AUC 0À2 h IFG: 56.8±9.0, IGT: 52.2±12.0 and NGT: 3.8±15.4 nmol Á 100 ml À1 min À1 , Po0.05 and P ¼ 0.057, respectively) in both IFG and IGT subjects. Conclusion: IFG, IGT and IFG/IGT subjects have lower insulin sensitivity and impaired b-cell function compared with age-and BMI-matched NGT controls. The increased postprandial TAG response and higher muscle TAG extraction in both IFG and IGT compared with NGT may lead to ectopic fat accumulation in the skeletal muscle, thereby contributing to insulin resistance.
Introduction
The prediabetic states, impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and a combination (IFG/ IGT), are the precursors of type 2 diabetes mellitus (T2DM) and are fueling this epidemic worldwide. The risk to progress to T2DM differs between these groups, with the lowest risk in IFG, followed by IGT and the highest risk in IFG/IGT compared with normal glucose tolerance (NGT) subjects. [1] [2] [3] [4] [5] Furthermore, impaired glucose metabolism (IGM) is associated with increased risk of cardiovascular events. 6, 7 To provide a basis for the development of tailored strategies to prevent or delay the onset of T2DM and cardiovascular diseases, it is important to obtain more insight into the pathogenesis of IFG, IGT and IFG/IGT. Several studies suggest that IFG, IGT and IFG/IGT represent distinct pathophysiological pathways toward T2DM, with only partial overlap [8] [9] [10] in both progressive loss of b-cell function and peripheral and hepatic insulin sensitivity. 5 However, there are still discrepancies between studies regarding differences in insulin sensitivity in subjects with IGM, which may partly be due to differences in methodology. In general, studies that used the gold-standard euglycemic-hyperinsulinemic clamp to assess insulin sensitivity have found lower peripheral insulin sensitivity in IGT but not in IFG subjects compared with NGT. 8, [10] [11] [12] [13] [14] In contrast, insulin sensitivity has been shown to be lower in both IFG and IGT subjects when estimated based on an oral glucose tolerance test (OGTT) or homeostasis model assessment for insulin resistance (HOMA IR ). [15] [16] [17] The underlying mechanisms for impairments in insulin sensitivity in subjects with IGM are not yet fully understood. Skeletal muscle and adipose tissue are important organs in regulating fatty acid (FA) metabolism. There is substantial evidence that impairments in skeletal muscle and adipose tissue function may contribute to the development of insulin resistance and T2DM. 18, 19 In insulin-resistant conditions, the capacity of the adipose tissue to store lipids (especially in the postprandial state) becomes insufficient, which could lead to an increased supply of free fatty acids (FFA) and triacylglycerol (TAG) to non-adipose tissues such as skeletal muscle and the liver ('lipid overflow' hypothesis). 18, 19 Consequently, when the uptake of FFA exceeds the capacity or the need to oxidize fat in skeletal muscle, the FFA are stored, leading to ectopic fat accumulation, which is associated with insulin resistance. 20, 21 We have previously demonstrated that skeletal muscle FA oxidation is diminished in T2DM 22, 23 during exercise and b-adrenergic stimulation and, interestingly, these impairments were already present in IGT subjects. 24 Furthermore, obese IGT subjects showed an impaired capacity to switch from fat to carbohydrate oxidation in the postprandial state as compared with obese NGT controls.
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The present study was performed to investigate insulin sensitivity in subjects with NGT, IFG, IGT and IFG/IGT using the gold-standard euglycemic-hyperinsulinemic clamp, a 75 g OGTT and HOMA IR . Second, skeletal muscle FA handling was assessed in a substudy to elucidate underlying mechanisms for diminished postprandial insulin sensitivity in IFG and IGT compared with NGT. An unique aspect of this study is that all groups were matched for age, BMI, blood pressure and gender distribution. This approach has not been frequently conducted and provides insight into differences ascribed to glucometabolic state.
Materials and methods
The current study was conducted within the framework of the PRESERVE (PancREatic b-cell dySfunction rEstoRed by Valsartan Effects) study, which is a controlled, multi-center trial, carried out in two different centers in the Netherlands (VU University medical center, Amsterdam and Maastricht University, Maastricht, The Netherlands). The medicalethical committee at each center approved the study protocol and all subjects gave their written informed consent before participating in the study. ) and 26 IFG/ IGT subjects were identified. Subjects with a blood pressure 4140/90 mm Hg were treated with amlodipine 5 mg. If blood pressure persisted 4140/90 mm Hg, the amlodipine dosage was increased to 10 mg. If this did not lower blood pressure to a level lower than 140/90, hydrochlorothiazide 12.5 mg and/or carvedilol 25 mg was added. Only subjects with a blood pressure o140/90 mm Hg were included in the study. None of the 102 subjects were taking any medications known to affect glucose metabolism. Exclusion criteria were excess alcohol intake (420 units per week), history of diabetes, hepatitis and/or pancreatitis, abnormal liver and renal function tests (42 times the upper limits of normal) and recent (o3 months) changes in weight ( ± 3 kg).
Subjects

Study design
Subjects came to the research center at 0800 h after an overnight fast (from 2200 h the previous evening). All subjects underwent a whole dual-energy X-ray absorptiometry (Hologic, QDR4500; Hologic, Waltham, MA, USA) to measure body composition, a 2 h 75 g OGTT (t0, t10, t20, t30, t60, t90 and t120 min), a combined euglycemichyperinsulinemic and hyperglycemic clamp procedure with additional arginine stimulation. In a subset of these subjects (n ¼ 35), fasting and postprandial skeletal muscle FA handling was examined at Maastricht University Medical Center. All measurements were completed within 5 weeks after screening.
Clamp
A combined euglycemic-hyperinsulinemic and hyperglycemic clamp, with subsequent arginine stimulation, was performed to assess insulin sensitivity 25 and insulin secretion. 26 A cannula was inserted retrogradely into a superficial dorsal hand vein, which was heated in a hotbox (60 1C) to obtain arterialized venous blood. In the contra lateral arm, a second cannula was introduced anterogradely in an antecubital vein of the forearm for the variable infusion of 20% glucose (IVAC560 pump, IVAC, San Diego, CA, USA) and insulin (40 mU m À2 min
À1
, Actrapid, Novo Nordisk Farma BV, Alphen aan den Rijn, The Netherlands, using a Harvard microinfusion pump, Plato BV, Diemen, The Netherlands). Arterialized blood samples were collected every 5 min to determine glucose concentration (EML 105, Radiometer, Copenhagen, Denmark). The amount of glucose infused was adjusted to maintain euglycemia at 5.0 mmol l
. After the euglyemic-hyperinsulinemic part of the clamp (t120 min) insulin infusion was discontinued for 60 min, while glucose was maintained at 5.0 mmol l
. After the euglycemichyperinsulinemic clamp, a hyperglycemic clamp was performed. To quantify insulin secretion, blood glucose concentration was rapidly raised to 15.0 mmol l À1 by
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At 80 min after induction of hyperglycemia, 5 g arginine dissolved in 50 ml was infused over 45 s to measure maximum insulin secretory capacity (t260), while the glucose concentration was maintained at 15.0 mmol l
.
Postprandial study
Forearm skeletal muscle metabolism was studied in a subset (n ¼ 35). A cannula was inserted retrogradely into a superficial dorsal hand vein, which was heated in a hotbox (60 1C) to obtain arterialized venous blood. In the contra lateral arm, a second catheter was introduced retrogradely in an antecubital vein of the forearm for sampling of deep venous blood draining forearm skeletal muscle. Arterialized and deep venous blood samples were simultaneously collected at three baseline time points (t30, t15 and t0 min) and at six time points (t30, t60, t90, t120, t180 and t240 min) after consumption of a standardized high-fat mixed meal (t0 min), containing 2. 
Biochemical methods
Plasma glucose concentrations were determined using a hexokinase method (Gluco-quant, Roche Diagnostics, Mannheim, Germany). FFA (Wako NEFA C kit, Sopar Biochemicals, Koekelberg, Belgium) was analyzed using standard enzymatic techniques automated on a Cobas Fara centrifugal spectrophotometer (Roche Diagnostica, Basel, Switzerland). Plasma TAG (Sigma; Diffchamb, Västa Frölunda, Sweden) and lactate (ABX Diagnostics, Montpellier, France) were analyzed enzymatically on a Cobas Mira automated spectrophotometer (Roche Diagnostica). Glycated hemoglobin (HbA 1c ) was measured by cation exchange chromatography (Menarini Diagnostics, Florence, Italy; reference values: 4.3-6.1%). Insulin and C-peptide concentrations were quantified using an immunometric assay (Advia, Centaur; Siemens Medical Solutions Diagnostics, Deerfield, IL, USA). The intra-assay precision ranged from 3-4% over a mean range from 20 to 1500 pmol l À1 for insulin and from 4-5% over a mean range from 0.13 to 40.5 nmol l À1 for C-peptide.
Calculations
Insulin sensitivity was determined by fasting measurements; HOMA IR , 27 by the OGTT-derived indices; insulin sensitivity index 8, 28 and OGIS 29 and during the euglycemic-hyperinsulinemic clamp; the M-value. During the euglycemic-hyperinsulinemic clamp, the M-value was calculated based on the last 30 min (steady state) and after adjustments for steady state insulin concentration (M/I). First-and second-phase C-peptide secretion during the hyperglycemic clamp was calculated as area under the curve (AUC 180À190 min and AUC 190À260 min , respectively) divided by the AUC 180À190 min and AUC 190À260 min glucose, respectively. Arginine-stimulated C-peptide secretion (AIR arg ) was calculated as the incremental AUC 260À270 min above the fasting C-peptide concentration divided by the AUC 260À270 min glucose concentration. The disposition index (DI 1stÀphase , DI 1st/2ndÀphase and DI Arg260À290 ) was determined by multiplying first, first-and second-phase, and arginine-stimulated insulin secretion with the M-value.
During the postprandial study, plasma flow was calculated by multiplying forearm blood flow with ((1-hematocrite)/100). A positive flux indicates net uptake across forearm muscle, whereas a negative flux indicates net release. For comparing postprandial responses, the AUC and incremental AUC (iAUC) were calculated for early (0-2 h), mid (2-4 h) and total (0-4 h after meal ingestion).
Body composition was measured by dual-energy X-ray absorptiometry. Upper body fat was determined by the trunk region, and lower body fat was determined by the left and right leg region.
Statistical analysis
Data are expressed as mean ± s.e.m. To obtain normal distribution, all variables that were not normally distributed were ln transformed. ANCOVA was applied to test for group differences in the multi-center study with gender and center as covariate. In the postprandial study, one-way analysis of variance (ANOVA) was used to test for group differences, as adjustment for gender did not affect the results. All statistical analyses were run on SPSS version 16.0 (SPSS, Chicago, IL, USA). A P-value o0.05 was considered statistically significant.
Results
Study 1: Insulin sensitivity and b-cell function Subjects' characteristics. Baseline characteristics of the subjects are summarized in Table 1 . There were no differences between NGT, IFG, IGT and IFG/IGT subjects with respect to age, BMI, total body fat percentage, W/H ratio, blood pressure and lipid profile (Table 1) .
OGTT: Insulin sensitivity. Insulin sensitivity, determined by insulin sensitivity index and OGIS, was significantly lower in the IFG, IGT and IFG/IGT compared with NGT subjects (Table 2 ). However, HOMA IR was significantly higher only in the IFG/IGT compared with NGT subjects (Table 2) .
Clamp: insulin sensitivity, C-peptide secretion and disposition index. IFG, IGT and IFG/IGT subjects had lower insulin sensitivity during the euglycemic-hyperinsulinemic clamp compared with NGT (M-value: 4.3 ± 0.2, 3.5 ± 0.7, 3.8 ± 0.4, 9.4±0.7 mg min À1 kg
À1
, respectively; ANCOVA Po0.001; Bonferroni Po0.001 for all), but no significant differences were found between subjects with IGM. Differences in C-peptide secretion are shown in Table 2 . In addition, IFG, IGT and IFG/IGT subjects had lower first-phase C-peptide secretion compared with NGT subjects. IFG/IGT subjects also showed severe defects in second-phase C-peptide secretion and a trend toward impaired C-peptide secretion during stimulation with the strong insulin-secretagogue arginine. The DI (first-phase, first-/second-phase and arginine-stimulated phase) was significantly lower in IFG, IGT and IFG/IGT compared with NGT subjects (Table 2) .
No significant gender differences were found in insulin sensitivity, insulin secretion and disposition index (data not shown). , respectively; ANOVA P ¼ 0.004; Bonferroni Po0.05 for both), but the difference in insulin sensitivity between IFG and IGT subjects did not reach statistical significance. Of note, NGT subjects that participated in the postprandial study had a higher BMI and were more insulin resistant as compared with the total group of NGT subjects in study 1.
Postprandial insulin sensitivity and circulating metabolites. Arterialized plasma glucose and insulin concentrations during fasting and postprandial conditions are shown in Figure 1 . Despite the significantly higher arterialized plasma insulin concentrations during the postprandial period in IFG and IGT compared with NGT subjects (AUC 0À4 h 9851 ± 1125, 10 425±884 and 5983±684 pmol l À1 , respectively, ANOVA Po0.05; Bonferroni Po0.05 for IFG and P ¼ 0.08 for IGT) (Figure 1b) , no significant differences were found in arterialized plasma glucose concentrations (AUC 0À4 h 1575±24, 1568±19 and 1612±41 mmol l À1 , respectively, ANOVA P ¼ 0.622) (Figure 1a) . Similarly, there were no differences in net forearm muscle glucose uptake (AUC 0À4 h 162±22, 101±14 and 135±25 mmol Á 100 ml À1 min À1 , respectively, ANOVA P ¼ 0.148) (Figure 2a ) in IFG and IGT when compared with NGT subjects. 
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Fasting arterialized plasma FFA and TAG concentrations were comparable between groups. Arterialized plasma FFA concentrations decreased during the first 2 h after intake of the mixed meal, and returned to near baseline values after 4 h in all groups (Figure 1c) . There was no difference in the postprandial decrease of plasma FFA concentration in the period from t0-90 min (iAUC 0À90 min ) between NGT, IFG and IGT subjects (À207.5 ± 18.5, À264.6 ± 24.0 and À221.8 ± 15.8 mmol l À1 min
À1
, respectively, P ¼ 0.118). However, the early postprandial TAG response (iAUC 0À2 h ) was significantly higher in the IFG and the IGT (ANOVA Po0.05; Bonferroni both Po0.05) compared with NGT subjects (iAUC 0À2 h 238.4±26.5, 234.0±41.0 and 82.6 ± 13.8 mmol l À1 min À1 , respectively) ( Figure 1d ).
Forearm muscle metabolism. Baseline forearm blood flow was significantly lower in the NGT compared with the IFG and IGT subjects (1.3±0.2, 2.3±0.1 and 2.1±0.2 ml Á 100 ml tissue À1 min
, respectively, P ¼ 0.006). However, forearm blood flow did not change in either group after intake of the high-fat mixed meal.
Net fasting glucose, lactate, FFA and TAG fluxes across forearm muscle were not significantly different between groups. Net lactate flux across forearm muscle increased during the first hour after the intake of the meal, and decreased to near baseline values after 4 h in all groups (Figure 2b) . Furthermore, net FFA flux across the forearm decreased during the first 90 min of the early postprandial phase, indicating reduced FFA uptake by forearm muscle, without significant differences between groups (Figure 2c) . Interestingly, net TAG extraction across forearm muscle was significantly higher in IFG and IGT (ANOVA Po0.05; Bonferroni Po0.05 and P ¼ 0.057, respectively) compared with NGT subjects during the early postprandial phase (AUC 0À2 h 56.8 ± 9.0, 52.2 ± 12.0 and 3.8 ± 15.4 nmol Á 100 ml À1 min À1 , respectively) ( Figure 2d ).
The early increase in plasma TAG concentration after intake of a high-fat mixed meal was strongly correlated with early net TAG extraction across skeletal muscle (r ¼ 0.716, Po0.001). In addition, fractional extraction of TAG tended to be higher in subjects with IGM (P ¼ 0.065).
Discussion
Individuals with IGM are at increased risk of developing T2DM. [1] [2] [3] [4] [5] However, the pathophysiological pathways that ultimately lead to T2DM may differ between IFG, IGT and Skeletal muscle lipid handling and glucose tolerance CCM Moors et al IFG/IGT subjects. The present study demonstrated that IFG, IGT and IFG/IGT had lower insulin sensitivity and impaired b-cell function compared with age-and BMI-matched NGT subjects. The substudy showed lower peripheral insulin sensitivity in IGT and increased insulin concentrations after a mixed meal without alterations in glucose concentrations and forearm glucose uptake, indicating lower postprandial insulin sensitivity in IFG and IGT compared with age-and BMI-matched NGT controls. This was accompanied by an increased postprandial TAG extraction in both groups, suggesting that an increased muscle fat storage may have a role in the progression toward impaired insulin sensitivity and subsequently the development of T2DM in both IFG and IGT subjects.
Insulin sensitivity Clamp and OGTT-derived peripheral insulin sensitivity. Insulin sensitivity was lower in IFG, IGT and IFG/IGT subjects compared with age-and BMI-matched NGT controls, either measured with the euglycemic-hyperinsulinemic clamp, the OGTT or derived from fasting measurements. Consistent with our findings, impairments in insulinstimulated glucose disposal in IGT and IFG/IGT subjects have been observed in many studies. 8, 10, [12] [13] [14] 17, 30, 31 8, 10, 13 insulin sensitivity in IFG compared with NGT subjects. A possible explanation for these discrepancies, in addition to differences in methodology, could be the differences in clinical staging (for example, number of years with IGM) and the (in)comparability of study groups; in many previous reports subjects with IGM were older, had higher body weight and more metabolic abnormalities compared with the control group. 8, 10, 11, 14, 17, 31, 32 The unique aspect of the present study is that all groups were matched for age, BMI, blood pressure and gender distribution. This approach provides insight into differences ascribed to impairments in glucose metabolism per se.
Postprandial insulin sensitivity. The postprandial net glucose flux across forearm muscle was not significantly different between groups, despite significantly higher postprandial insulin concentrations in IFG and IGT compared with NGT subjects. These data suggest postprandial skeletal muscle insulin resistance in IFG and IGT subjects compared with NGT controls. Although the hyperinsulinemic-euglycemic clamp is the gold standard for measuring insulin sensitivity, meal-derived insulin sensitivity is not only an insulin challenge but reflects a postprandial effect because it involves the oral route of delivery, the associated incretin hormone secretion and the presence of non-glucose nutrients stimulation during ingestion of a mixed meal and is, therefore, a more physiological test.
Forearm muscle metabolism
There is substantial evidence that disturbances in skeletal muscle FA handling may have an important role in the etiology of insulin resistance and T2DM. The present study is, to our knowledge, the first to examine skeletal muscle FA handling in NGT, IFG and IGT subjects matched for age and BMI. As expected, net glucose uptake across forearm muscle significantly increased, whereas net FFA uptake significantly decreased after intake of the mixed meal in all groups, reflecting a shift from fat to carbohydrate utilization in the early postprandial period. The increase in plasma TAG concentrations during the early postprandial period was significantly higher in both IFG and IGT compared with NGT subjects. Net TAG extraction across forearm muscle was also significantly higher in these subjects during the early postprandial phase. Interestingly, we demonstrated that early the increase in plasma TAG concentration after intake of the high-fat mixed meal was strongly associated with early net TAG extraction across skeletal muscle, indicating that TAG supply to the skeletal muscle may determine TAG extraction. These results are in line with the recent findings of our group, 35 showing that insulin-resistant men have an increased postprandial forearm muscle TAG uptake. The higher TAG extraction could be related to postprandial hyperinsulinemia in the IGM group, which may underlie higher skeletal muscle lipoprotein lipase activity. Furthermore, the FA transporter CD36 is acutely upregulated during insulin stimulation. 36 Thus, increased CD36 content in skeletal muscle, as a consequence of hyperinsulinemia, may also contribute to higher TAG extraction in subjects with IGM. A reduced FA oxidation, alterations in skeletal muscle FA delivery and uptake may contribute to excessive fat storage in skeletal muscle. Therefore, the observed disturbances in TAG handling in IFG and IGT may lead to increased lipid storage in skeletal muscle in the postprandial period, which is closely associated with insulin resistance and may contribute to the progression of overt T2DM. 20, 21 Further research is necessary to elucidate underlying mechanisms such as skeletal muscle FA oxidation and intramuscular lipid storage in these groups.
Insulin secretion T2DM is characterized by b-cell dysfunction against a background of impaired insulin sensitivity. Similar to impaired insulin sensitivity, b-cell dysfunction may already be present in subjects with IGM. However, only few studies have measured first-and second-phase C-peptide secretion with the hyperglycemic clamp comparing IFG, IGT and Skeletal muscle lipid handling and glucose tolerance CCM Moors et al IFG/IGT with NGT controls. 8, 11, 14, 37 The present study demonstrated that first-phase C-peptide secretion was lower in subjects with IGM compared with age-and BMI-matched NGT subjects. IFG/IGT subjects also showed severe defects in second-phase C-peptide secretion and a trend toward impaired C-peptide secretion during stimulation with the strong insulin-secretagogue arginine, which is consistent with longitudinal studies showing a higher risk of progression to T2DM in the combined IFG/IGT subjects compared with IFG and IGT. 2 In conclusion, the present study demonstrated that IFG, IGT and IFG/IGT subjects have lower peripheral insulin sensitivity and impaired b-cell function compared with ageand BMI-matched NGT controls. The decreased postprandial insulin sensitivity was accompanied by higher postprandial TAG concentration and increased TAG extraction across skeletal muscle in IFG and IGT. These impairments may lead to increased fat storage in the skeletal muscle and contribute to the progression of overt T2DM in these individuals.
